Supplementary Table S5 from Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S5: Molecular features of patient-derived LMS models from Champions Oncology used in in vivo validation studies (five LMS PDX), including clinical and morphological features of LMS tumors from which they were derived.
创建时间：
2023-12-15
